A Post-marketing Surveillance to Assess Safety and Efficacy of Telostop Plus Tab.
NCT03648801 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600
Last updated 2018-08-31
Summary
Post-marketing surveillance of Telostop Plus Tab.
Conditions
- Hypertension, Dyslipidemia
Sponsors & Collaborators
-
IlDong Pharmaceutical Co Ltd
lead INDUSTRY
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-09-30
- Primary Completion
- 2024-05-31
- Completion
- 2024-08-31
More Related Trials
-
Nice Morning- Safety and Efficacy Observational Study of Telmisartan in Hypertensive Patients in Multicenters
NCT00615108 ·Status: COMPLETED
-
S-amlodipine+Chlorthalidone vs S-amlodipine+Telmisartan in Hypertension
NCT03226340 ·Status: UNKNOWN ·Phase: PHASE4
-
A Regulatory Requirement Post-Marketing Surveillance Study to Monitor the Safety and Efficacy of Twynsta (Telmisartan + Amlodipine SPC, q.d.) in Korean Hypertensive Patients Requiring Combination Therapy
NCT01243268 ·Status: COMPLETED
-
Efficacy and Safety of Telmisartan and Losartan in Primary Hypertension
NCT02269176 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
NCT07090161 ·Status: RECRUITING ·Phase: PHASE2
-
Additional Effect of A Life Style Program on Antihypertensive Treatment With Telmisartan
NCT01108796 ·Status: COMPLETED
-
Clinical Efficacy and Safety Evaluation of Irbesartan and Amlodipine Combined Therapy in Essential Hypertension Patients
NCT05476354 ·Status: COMPLETED ·Phase: PHASE3
-
Post-Marketing Surveillance Study of Micardis® Plus in Patients With Hypertension
NCT02238275 ·Status: COMPLETED
-
Efficacy and Safety of TAH Combination in Comparison With Telmisartan/Amlodipine Combination for Essential Hypertension Patients
NCT02738632 ·Status: COMPLETED ·Phase: PHASE3
-
Post-marketing Surveillance Study With MicardisPlus® in Treatment of Morning Hypertension (Self-monitored by Patient)
NCT02243566 ·Status: COMPLETED
-
Twynsta Study With Lifestyle Modifications in Korean Patients With Hypertension
NCT01316419 ·Status: COMPLETED
-
An Observational Study to Investigate the Efficacy, Safety, Tolerability and the Effect on Quality of Life of Telmisartan (Micardis) and Telmisartan With HCTZ (Micardis Plus) in Patients With Hypertension
NCT00904215 ·Status: COMPLETED
-
A Randomized, Double-blind, Parallel-group Assessment of the Safety and Efficacy of Telmisartan 40mg Plus Hydrochlorothiazide 12.5mg (Micardis Plus) in Comparison With Losartan 50mg Plus Hydrochlorothiazide 12.5mg in Taiwanese Patients With Mild to Moderate Hypertension
NCT00133185 ·Status: COMPLETED ·Phase: PHASE3
-
Post-Marketing Surveillance of Micardis® (Telmisartan) in Patients With Hypertension
NCT02242838 ·Status: COMPLETED
-
Efficacy and Safety of Telmisartan Compared With Losartan
NCT06431477 ·Status: RECRUITING ·Phase: PHASE4
-
Post Marketing Surveillance (PMS) Study to Assess Safety and Efficacy of Micardis in Patients With Essential Hypertension
NCT02245464 ·Status: COMPLETED
-
Clinical Efficacy and Safety Evaluation of Irbesartan High and Amlodipine Combined Therapy in Essential Hypertension Patients
NCT05475665 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Efficacy and Safety Evaluation of HCP1904-2 in Essential Hypertension Patients
NCT04830449 ·Status: COMPLETED ·Phase: PHASE3
-
Duowell® vs. Telmisartan Monotherapy in Mild Dyslipidemia Patients With Hypertension
NCT03267329 ·Status: COMPLETED ·Phase: PHASE4
-
Drug-drug Interaction Study (Telmisartan, Amlodipine, Chlorthalidone)
NCT02152969 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of HL-040XC in Essential Hypertension and Hyperlipidemia
NCT01541943 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Zilebesiran in Japanese Patients With Mild to Moderate Hypertension
NCT06423352 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Telmisartan+HCTZ (Hydrochlorothiazide), Hypertension
NCT00659607 ·Status: COMPLETED
-
Clinical Efficacy and Safety Evaluation of HCP1904-1 in Essential Hypertension Patients
NCT04820907 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study to Evaluate Combination Therapy With Nebivolol and Lisinopril vs. Placebo and Monotherapy in Patients With Stage 2 Diastolic Hypertension
NCT01218100 ·Status: COMPLETED ·Phase: PHASE4